262 related articles for article (PubMed ID: 23486132)
1. Mohs versus surgical excision in nonmelanoma skin cancers: does location matter?
Pereira CT; Kruger EA; Sayer G; Kim J; Hu J; Miller TA; Rudkin GH
Ann Plast Surg; 2013 Apr; 70(4):432-4. PubMed ID: 23486132
[TBL] [Abstract][Full Text] [Related]
2. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
[TBL] [Abstract][Full Text] [Related]
3. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
[TBL] [Abstract][Full Text] [Related]
4. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
[TBL] [Abstract][Full Text] [Related]
5. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery.
Zabielinski M; Leithauser L; Godsey T; Gloster HM
Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725
[TBL] [Abstract][Full Text] [Related]
6. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
[TBL] [Abstract][Full Text] [Related]
7. Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites.
Nizamoglu M; Douglas H; McArdle C; Mathew B; Vize C; Matteucci P
J Plast Reconstr Aesthet Surg; 2016 May; 69(5):657-62. PubMed ID: 26850755
[TBL] [Abstract][Full Text] [Related]
8. Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size.
Duffy KL; McKenna JK; Hadley ML; Tristani-Firouzi P
Dermatol Surg; 2009 Jan; 35(1):30-3. PubMed ID: 19018813
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of Mohs micrographic surgery: review of the literature.
Tierney EP; Hanke CW
J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
[TBL] [Abstract][Full Text] [Related]
11. Eighteen years of experience in Mohs micrographic surgery and conventional excision for nonmelanoma skin cancer treated by a single facial plastic surgeon and pathologist.
van der Eerden PA; Prins ME; Lohuis PJ; Balm FA; Vuyk HD
Laryngoscope; 2010 Dec; 120(12):2378-84. PubMed ID: 21046543
[TBL] [Abstract][Full Text] [Related]
12. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma.
Walling HW; Scupham RK; Bean AK; Ceilley RI
J Am Acad Dermatol; 2007 Oct; 57(4):659-64. PubMed ID: 17870430
[TBL] [Abstract][Full Text] [Related]
13. Wide excision or Mohs micrographic surgery for the treatment of primary dermatofibrosarcoma protuberans.
Meguerditchian AN; Wang J; Lema B; Kraybill WG; Zeitouni NC; Kane JM
Am J Clin Oncol; 2010 Jun; 33(3):300-3. PubMed ID: 19858696
[TBL] [Abstract][Full Text] [Related]
14. A Predictive Model for Primary Closure Lengths in Mohs Surgery Based on Skin Cancer Type, Dimensions, and Location.
Theroux ZA; Blechman AB; Russell MA
Dermatol Surg; 2019 Jan; 45(1):36-43. PubMed ID: 29894432
[TBL] [Abstract][Full Text] [Related]
15. Survival Outcomes of Mohs Surgery versus Wide Local Excision for Less Common Nonmelanoma Skin Cancers: A Stabilized Inverse Probability of Treatment Weighting Analysis.
Chen M; Yunqiong Wang Y
Dermatology; 2023; 239(6):877-888. PubMed ID: 37699383
[TBL] [Abstract][Full Text] [Related]
16. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
[TBL] [Abstract][Full Text] [Related]
17. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial.
Smeets NW; Krekels GA; Ostertag JU; Essers BA; Dirksen CD; Nieman FH; Neumann HA
Lancet; 2004 Nov 13-19; 364(9447):1766-72. PubMed ID: 15541449
[TBL] [Abstract][Full Text] [Related]
18. Dermatofibrosarcoma protuberans: margins reduction using slow-Mohs micrographic surgery. Experience with 35 patients.
Chaput B; Filleron T; Le Guellec S; Meresse T; Courtade-Saïdi M; Grolleau JL; Chevreau C; Garrido I; Gangloff D
Ann Chir Plast Esthet; 2014 Aug; 59(4):219-25. PubMed ID: 24411817
[TBL] [Abstract][Full Text] [Related]
19. Nonmelanoma Skin Cancer With Aggressive Subclinical Extension in Immunosuppressed Patients.
Song SS; Goldenberg A; Ortiz A; Eimpunth S; Oganesyan G; Jiang SI
JAMA Dermatol; 2016 Jun; 152(6):683-90. PubMed ID: 26981734
[TBL] [Abstract][Full Text] [Related]
20. [Complete treatment of basal cell carcinoma; cost effectiveness of Mohs micrographic surgery versus conventional excision].
Muche JM; van Rengen A; Mosterd K
Ned Tijdschr Geneeskd; 2017; 161():D1549. PubMed ID: 29303086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
